• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: AUGMENIX, INC. SPACEOAR SYSTEM; ABSORBABLE PERIRECTAL SPACER

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

AUGMENIX, INC. SPACEOAR SYSTEM; ABSORBABLE PERIRECTAL SPACER Back to Search Results
Model Number SO-2101
Device Problem Adverse Event Without Identified Device or Use Problem (2993)
Patient Problems Abscess (1690); Unspecified Infection (1930); Necrosis (1971); Urinary Retention (2119); Obstruction/Occlusion (2422); Abdominal Distention (2601); No Code Available (3191)
Event Date 12/12/2019
Event Type  Injury  
Manufacturer Narrative
The complainant was unable to provide the suspect device lot number.Therefore, the expiration and device manufacture dates are unknown.(b)(4).The device was implanted and will not be returned for evaluation; therefore a failure analysis of the complaint device could not be completed.If any further relevant information is identified, a supplemental medwatch will be filed.
 
Event Description
It was reported to boston scientific corporation on december 17, 2019 that spaceoar was implanted between the prostate and anterior rectal wall during a spaceoar placement procedure performed on (b)(6) 2019.Reportedly, the procedure was done under local anesthesia and there were no issues noted during spaceoar placement.However, it was reported that the procedure took a long time and they needed a few extra sticks in order to correctly place the gold markers.According to the complainant, after the procedure, the patient tried to urinate before leaving the hospital but was unable to do so.The patient also declined to take cipro, an antibiotic administered by the hospital.Reportedly, the night of (b)(6) 2019, the patient went to the emergency room (er) for retention per the recommendation of the physician's assistant.At the er, the patient's white blood cell (wbc) count was elevated.The wbc count dropped back to a normal level after a few days of treatment.The patient's platelet count was normal.On (b)(6) 2019, a computerized tomography (ct) scan was performed in the er.A linear tract of extraluminal air between the rectum and prostate gland and additional fluid density was observed, which was reported to be expected after hydrogel implantation.On (b)(6) 2019, another ct scan was performed.The ct scan revealed no evidence of active bleeding.The ct scan showed that the internal mesenteric artery (ima) was occluded.There was a small bowel obstruction with dilation of the proximal jejunum.Increased fat stranding near sigmoid colon, which may represent colitis, was also observed.On (b)(6) 2019, a magnetic resonance imaging (mri) scan was also performed.A small amount of ill-defined fluid between the anterior wall of rectum and posterior prostate was observed.No rim-enhancing drainable collections were observed in the pelvis.There were signs of devitalization along the right lateral wall of the rectum and posterior prostate as well as in the intervening soft tissues.Continued small bowel obstruction and mild distention of the sigmoid colon were observed.Per the mri report, the spaceoar was placed correctly.On (b)(6) 2019, it was reported that the patient had urinary issues.A colonoscopy was performed and did not show any bowel issues.As of (b)(6) 2019, the patient had a diverting ostomy and it is unknown if the patient is still hospitalized.The patient has not received his stereotactic body radiation treatment yet.
 
Event Description
It was reported to boston scientific corporation on (b)(6), 2019 that spaceoar was implanted between the prostate and anterior rectal wall during a spaceoar placement procedure performed on (b)(6) 2019.Reportedly, the procedure was done under local anesthesia and there were no issues noted during spaceoar placement.However, it was reported that the procedure took a long time and they needed a few extra sticks in order to correctly place the gold markers.According to the complainant, after the procedure, the patient tried to urinate before leaving the hospital but was unable to do so.The patient also declined to take cipro, an antibiotic administered by the hospital.Reportedly, the night of (b)(6), 2019, the patient went to the emergency room (er) for retention per the recommendation of the physician's assistant.At the er, the patient's white blood cell (wbc) count was elevated.The wbc count dropped back to a normal level after a few days of treatment.The patient's platelet count was normal.On (b)(6) 2019, a computerized tomography (ct) scan was performed in the er.A linear tract of extraluminal air between the rectum and prostate gland and additional fluid density was observed, which was reported to be expected after hydrogel implantation.On (b)(6), 2019, another ct scan was performed.The ct scan revealed no evidence of active bleeding.The ct scan showed that the internal mesenteric artery (ima) was occluded.There was a small bowel obstruction with dilation of the proximal jejunum.Increased fat stranding near sigmoid colon, which may represent colitis, was also observed.On(b)(6) 2019, a magnetic resonance imaging (mri) scan was also performed.A small amount of ill-defined fluid between the anterior wall of rectum and posterior prostate was observed.No rim-enhancing drainable collections were observed in the pelvis.There were signs of devitalization along the right lateral wall of the rectum and posterior prostate as well as in the intervening soft tissues.Continued small bowel obstruction and mild distention of the sigmoid colon were observed.Per the mri report, the spaceoar was placed correctly.On (b)(6), 2019, it was reported that the patient had urinary issues.A colonoscopy was performed and did not show any bowel issues.As of (b)(6), 2019, the patient had a diverting ostomy and it is unknown if the patient is still hospitalized.The patient has not received his stereotactic body radiation treatment yet.
 
Manufacturer Narrative
Block d4, h4: the complainant was unable to provide the suspect device lot number.Therefore, the expiration and device manufacture dates are unknown.Block h6: patient code 2119 captures the reportable event of urinary retention.Patient code 3191 is being used in lieu of an appropriate term for surgery.Patient code 1690 captures the reportable event of abscess.Patient code 1930 captures the reportable event of infection requiring treatment.Patient code 2422 captures the reportable event of bowel obstruction requiring surgical treatment.Evaluation conclusion code 4316 is being used in lieu of an adequate conclusion code for device not returned.Block h10: the device was implanted and will not be returned for evaluation; therefore a failure analysis of the complaint device could not be completed.If any further relevant information is identified, a supplemental medwatch will be filed.Block h11: h6 (patient code) has been updated.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
SPACEOAR SYSTEM
Type of Device
ABSORBABLE PERIRECTAL SPACER
Manufacturer (Section D)
AUGMENIX, INC.
201 burlington road
bedford MA 01730
MDR Report Key9586105
MDR Text Key178332302
Report Number3005099803-2020-00021
Device Sequence Number1
Product Code OVB
UDI-Device Identifier00864661000102
UDI-Public00864661000102
Combination Product (y/n)N
PMA/PMN Number
K181465
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type company representative,health
Type of Report Initial,Followup
Report Date 02/18/2020
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Health Professional
Device Model NumberSO-2101
Device Catalogue NumberSO-2101
Was Device Available for Evaluation? No
Initial Date Manufacturer Received 12/17/2019
Initial Date FDA Received01/14/2020
Supplement Dates Manufacturer Received02/04/2020
Supplement Dates FDA Received02/18/2020
Is This a Reprocessed and Reused Single-Use Device? No
Patient Sequence Number1
Patient Outcome(s) Required Intervention;
-
-